Author(s): Lama Talal Khrais, Noor Aina Amirah
The pharmaceutical industry is directly linked to human lives and faces disturbing problems. Therefore, the European foundation for quality management’s enablers minimizes risks associated with deficiency of medicines, technological development, and experience. The study was carried out to find the Effect of the European foundation for quality management’s enablers on Jordanian pharmaceutical companies to gain competitive advantages. 100 respondents were randomly selected from 15 pharmaceutical companies in Jordan. An exploratory factor analysis was performed and a structured questionnaire was used to summarize the research objectives. Research has shown the effectiveness of EFQM Enablers in gaining a competitive advantage. Finally, reliability testing was performed to determine acceptable levels. The study expands the scope of European foundation for quality management’s enablers (EFQM) enablers for Jordanian pharmaceutical companies. However, this study is geographically limited and should be extended to other regions. Moreover, the study results should serve as insightful numbers for Jordanian pharmaceutical companies in identifying persistent performance issues